CTVA: 10-K Risk Factor Changes

2026 vs 2025  ·  SEC EDGAR  ·  2026-10-16
⚠ AI Risk Brief Interpretation layer — deterministic data below

Corteva faces heightened regulatory risk from government funding cuts and new separation complexity amid competitive pressures.

Direction ↑ More concerning
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

2
New Risks
2
Removed
2
Modified
25
Unchanged
🟢 New in Current Filing Disclosure change8/10

Recent funding and staff reductions, including at the EPA, the USDA, the FDA and the U.S. Department of Health and Human Services ("HHS"), could hinder our ability to receive timely regulatory approvals.

🟢 New in Current Filing Corteva is subject to risks related to its plans to separate its seed and crop protection businesses in a spin-off that will result in two standalone public companies, including that the proposed separation may not be completed on the contemplated timeline or at all and may not achieve the intended benefits. 🔒
🔴 No Match in Current Filing EIDP has identified a material weakness in its internal control over financial reporting, which could negatively impact the accurate and timely reporting of its results of operations and financial condition. 🔒
🔴 No Match in Current Filing DuPont is currently disputing with Corteva certain provisions of the Separation Agreement and Tax Matters Agreement. 🔒

And 2 more changes in the full comparison.

5 more changes in this filing

Full diff access, historical comparisons, and cross-company signal tracking.

Get Pro access Already a Pro subscriber? View full diff →